Literature DB >> 12909541

Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.

Ch B Felder1, M J Blanco-Príeto, J Heizmann, H P Merkle, B Gander.   

Abstract

Peptide and protein microencapsulation into poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) microspheres continues to represent a technological challenge in terms of product sterility and up-scaling. The primary objective of this study was to examine the feasibility of a novel method for peptide and protein entrapment into PLA and PLGA microspheres, particularly suitable for up-scaling and aseptic processing. The method involves ultrasonic atomization of an organic polymer solution combined with subsequent organic solvent extraction by a hardening agent. The study evaluated the critical atomization conditions, the required molecular cohesion parameters of polymer solvents and hardening agent for particle preparation as well as the quality of entrapment and release as a function of polymer and peptide/protein type. Suitable polymer solvents and hardening agents were restricted to defined domains of fractional cohesion parameters: f(p) = 0.2-0.35 and f(h) = 0.2-0.4 for the polymer solvents, and f(p) = 0-0.1 and f(h) = 0-0.25 for the hardening agents. Microsphere size (0.1-100 micro m) was largely controlled by the viscosity of the atomized solution. Microencapsulation of the freely water-soluble bovine serum albumin and tetrapeptide thymocartin yielded modest efficiencies of 12-35%, whereas the slightly water-soluble octapeptide vapreotide pamoate was entrapped with 63-93% efficiency. Drug release was mainly governed by the polymer type, lasting over 100 days for BSA entrapped in PLA microspheres and; 20 days for vapreotide pamoate in PLGA 50 : 50 and for thymocartin in PLA. Very importantly, the novel method was readily accommodated within a laminar air-flow cabinet. Under aseptic conditions, sterile microspheres could be prepared. In conclusion, the novel method described may have potential in industrial environments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909541     DOI: 10.1080/0265204031000148059

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  7 in total

Review 1.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

2.  Plasma sterilization of poly lactic acid ultrasound contrast agents: surface modification and implications for drug delivery.

Authors:  John R Eisenbrey; Jennifer Hsu; Margaret A Wheatley
Journal:  Ultrasound Med Biol       Date:  2009-09-19       Impact factor: 2.998

3.  Microencapsulation: A promising technique for controlled drug delivery.

Authors:  M N Singh; K S Y Hemant; M Ram; H G Shivakumar
Journal:  Res Pharm Sci       Date:  2010-07

4.  Effect of Lipid Additives and Drug on the Rheological Properties of Molten Paraffin Wax, Degree of Surface Drug Coating, and Drug Release in Spray-Congealed Microparticles.

Authors:  Hongyi Ouyang; Audrey Yi Zheng; Paul Wan Sia Heng; Lai Wah Chan
Journal:  Pharmaceutics       Date:  2018-06-26       Impact factor: 6.321

5.  Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin.

Authors:  Eleftherios Halevas; Chrysoula Kokotidou; Elda Zaimai; Alexandra Moschona; Efstratios Lialiaris; Anna Mitraki; Theodore Lialiaris; Anastasia Pantazaki
Journal:  Pharmaceutics       Date:  2021-01-16       Impact factor: 6.321

Review 6.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

Review 7.  Biodegradable polymers for microencapsulation of drugs.

Authors:  Jae Hyung Park; Mingli Ye; Kinam Park
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.